INTRODUCTION
There are still two major unknowns that have not been fully elucidated in hematopoiesis. The first is the phenotype of the cells that become specified to hemato/lymphopoiesis during embryogenesis and the second is the phenotype of the most primitive precursor of hematopoietic stem cells (HSCs) residing in adult hematopoietic organs.
The origin of hematopoiesis is biphasic, starting from primitive hematopoiesis and culminating in definitive hematopoiesis, 1, 2 and in the developing embryo two separate anatomical sites have been identified where these processes occur. Specifically, during the primitive phase of hematopoiesis, the first hematopoietic precursor cells are identified outside the embryo proper in the socalled hematopoietic islands at the bottom of the yolk sac. 1, [3] [4] [5] [6] The blood islands are believed to develop from putative hemangioblasts, which give rise to endothelial precursors and HSCs. 7 Definitive hematopoiesis is observed later in embryonic development when the first HSCs become specified in the dorsal aorta wall in the so-called hematogenic endothelium. 8, 9 This area is part of a wider anatomical area of the embryo known as the aortagonado-mesonephros (AGM) region. What is important for the subject of this review, is that initiation of both primitive and definitive hematopoiesis is tightly connected with the migration of primordial germ cells (PGCs). 5, 6, [9] [10] [11] [12] In this review, I will present the concept that a subpopulation of cells related to migrating PGCs could be responsible for establishing hematopoiesis in both places.
Returning to the second issue, it is accepted that not all stem cells with hematopoietic potential are equal, and some very rare HSCs are more developmentally primitive than others. Therefore, the quest for the most primitive HSCs still continues, and several potential candidates have been proposed. 13, 14 What is important in this review, I will present the concept that a rare population of PGC-descendant stem, cells residing in adult tissues, termed very small embryonic-like stem cells (VSELs), are precursors of longterm repopulating HSCs (LT-HSCs). 15, 16 We envision that VSELs could be (i) the main precursor or (ii) a reserve source of LT-HSCs. 17 In sum, the expression of functional sex hormone receptors on PGCs, VSELs and HSCs connects these two provocative concepts, 12, [17] [18] [19] and this somewhat challenging point of view about hematopoiesis will be critically discussed in the current review. testes. 24 Interestingly, in direct mutagenesis studies, it has also been demonstrated that BM cells exposed to methylchloranthrene may give rise to germline tumors. 25 Finally, in a very recent study, murine BM-derived VSELs have been demonstrated to differentiate into germline cells. 18 Below, I will discuss the potential developmental link between PGCs and hematopoiesis.
EVIDENCE FOR THE PRESENCE OF CELLS WITH GERMLINE POTENTIAL IN ADULT BM

PGCS AND HEMATOPOIESIS-SUPPORTIVE EVIDENCE FOR THE EXISTENCE OF A LINK
PGCs are specified in the proximal epiblast, which is an anatomical region derived from the pluripotent stem cell cluster in the inner cell mass of the blastocyst and can be anatomically distinguished shortly after implantation of the blastocyst into the uterus. 26 The epiblast gives rise to all three germ layers (meso-, ecto-, and endoderm) as well as gametes. What is intriguing and relevant for this review, PGCs are the very first stem cells to become specified in the mouse proximal epiblast, 6.25 days post coitum (dpc). 27 Shortly after this, PGCs leave the developing embryo proper and migrate to the extraembryonic endoderm toward the yolk sac at the bottom of the allantois, where they become visible as a group of 50 alkaline phosphatase-positive cells at 7.5 dpc. 28 This is around the time when the first hemangioblasts and hematopoietic islands emerge in this area of the embryo. 29 Subsequently, PGCs, which are continuously amplified during the migration process, leave the extraembryonic endoderm and return to the embryo proper. They then enter the so-called primitive streak and migrate towards the genital ridges, where ultimately, between 12.5 and 14.5 dpc, they will settle and give rise to gametes. 30 Before this occurs, PGCs on their way to the genital ridges cross the AGM region on day 11 dpc, as mentioned above. 5, 9, 30, 31 During their migration in extraembryonic tissue and later in the embryo proper, PGCs not only amplify in number but also change the expression of certain genes, so that, based on their molecular signature, we can distinguish three developmental stages of these cells: (i) early-migrating, (ii) migrating and (iii) post-migrating PGCs. 11, 31 While post-migrating PGCs ultimately establish gametogenesis, early PGCs, which I will discuss below, could theoretically give rise to hemangioblasts and initiate primitive hematopoiesis in the yolk sac blood islands, and late-migratory PGCs could give rise to definitive hematopoiesis in the AGM region, where the first HSCs can be identified that are associated with the aortic endothelium. [30] [31] [32] Currently, it is widely accepted that-due to the initiation of circulation via the blood stream, which requires a beating heartHSCs from the blood islands colonize different areas of the endothelium in large vessels, including the dorsal aortic wall in AGM region. 9 In support of this mechanism, murine Ncx1-KO embryos, which do not develop a beating heart by 8.25 dpc but still continue to develop until 10 dpc, do not initiate definitive hematopoiesis. 2, 33 Specifically, while there was no significant difference in the number of hematopoietic precursors in the yolk sacs from wild type and Ncx1-KO embryos, the embryo proper, including the AGM region, was nearly devoid of HSCs in mutant animals. 2, 34 However, this concept that HSCs from the yolk sac may specify into definitive HSCs and colonize aortic endothelium, does not preclude the possibility that the aortic endothelium could be colonized by PGC-derived cells migrating through the AGM region by 11 dpc in mice. [30] [31] [32] For the initiation of definitive hematopoiesis in the aortic endothelium, it is known that there is an effect induced by shear forces from active blood flow. 35 Again, we cannot preclude that these shear forces act on migrating PGC-derived cells that infiltrate the aortic endothelium.
In support of the intriguing concept that HSCs may be derived from PGCs, 12, 36, 37 it has been demonstrated that PGCs isolated from murine embryos, stem cells isolated from murine testes 38 and certain teratocarcinoma cell lines 39 can be specified into HSCs. By contrast, the 'hematopoietic' functional erythropoietin receptor (EpoR) is expressed in germline-derived tumors such as murine and human teratocarcinoma and gonadal tumor cell lines. 40 Moreover, there are reports on the clonal origin of both teratomas and germline leukemia tumors. [41] [42] [43] An important factor in the development of PGCs is the transforming growth factor β-related factor bone morphogenetic protein 4 (BMP-4). 44 It has been reported that BMP-4 is expressed in the AGM coincident with the emergence of HSCs and also stimulates postnatal HSCs in in vitro assays. 45 Moreover, in an elegant, recently published paper employing mouse PGCs marked by the transgene green fluorescence protein (GFP) driven by the germ cell-specific promoter or enhancer region of the Oct3/4 gene, the authors found that the cell population moving toward the gonadal ridges and usually identified as PGCs encompasses a subset of cells co-expressing several germ cell and hematopoietic markers with hematopoietic activity. These cells that settled in the AGM region, expressed various Oct3/4-positive cell populations showing distinct expression of PGC markers (Blimp-1, AP, Tg-1, Stella) and at the same time several proteins and genes for hematopoietic precursors, such as CD34, CD-41, FLK-1, Brachyury, Hox-B4, Scl/Tal-1 and Gata-2. In particular, Oct3/4-GFP-weak CD34-weak/high cells exhibited robust hematopoietic colonyforming activity in vitro.
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FROM PGCS TO VSELS-HOW MUCH EVIDENCE EXISTS?
It has been proposed that adult tissues, including murine and human bone marrow (BM), human umbilical cord blood (UCB), and mobilized peripheral blood (mPB), harbor a population of very rare small stem cells with pluri-or multi-potential differentiation. In fact, it has been proposed that during embryogenesis, some stem cells related to migrating PGCs escape specification into tissue-committed stem cells, retain their pluripotent character and survive as a population of very small embryonic-like stem cells (VSELs) into adulthood, thus forming a reserve 'back-up pool' of stem cell precursors for adult issues. 17, 46, 47 VSELs are slightly smaller than mature erythrocytes. 48 The small size of these cells (~3-5 μm in mice and 4-7 μm in humans) and the paucity of mitochondria are signs of their quiescence and low metabolic activity. BM-derived VSELs are, in fact, very rare (~0.01-0.001% of nucleated BM cells) and have been shown to be precursors of several types of stem cells, including HSCs, mesenchymal cells (MSCs), 49 Both murine and human BM-derived VSELs express several pluripotent stem cell markers, including Oct4, Nanog, Rex-1 and SSEA-1 (murine VSELs) or SSEA-4 (human VSELs). 46, 57 Studies performed on highly purified double-sorted VSELs isolated from murine BM revealed that these cells highly express, at the mRNA and/or protein levels, genes involved both in specification of the epiblast (for example, Stella, Prdm14, Fragilis, Blimp1, Nanos3 and Dnd1) and late-migratory PGCs (for example, Dppa2, Dppa4 and Mvh). 58 Moreover, the main intrinsic molecular mechanisms that keep VSELs quiescent in adult tissues are similar to those that govern quiescence of PGCs and are based on epigenetic modification of some parentally imprinted genes. 59 Specifically, VSELs, like post-migratory PGCs, modify the imprinting of certain early-development parentally imprinted gene loci, including Igf2-H19, which results in their resistance to insulin/ insulin like-growth factor (IIS) signaling, and, by modifying imprinting at the KCNQ1/p57
Kip2 locus, upregulate in parallel the cyclin-dependent kinase inhibitor p57 KIP2 . 58, 60 We also observed significant differences in the expression of certain miRNA species, including (i) miRNA-675-3p, miRNA-675-5p, miRNA-292-5p, miRNA-184 and miRNA-125b, whose upregulation attenuates the abovementioned IIS signaling, and (ii) miRNA-25-1 and miRNA--19b, whose downregulation has the effect of upregulating the cell cycle checkpoint.
Therefore, the expression in VSELs of genes characteristic of migrating PGCs, 62 the germline specification of VSELs, 18, 40 and the fact that similar epigenetic changes control the quiescent state of PGCs and VSELs in adult tissues due to modification of imprinting at regulatory regions in paternally imprinted genes, 58,60 all strongly support a potential developmental link between these cell populations. Other similarities include (i) the similar expression of functional receptors for erythropoietin 60 and vitamin D3, 63 (ii) the hematopoietic specification of both types of cells, 16, 18, 36 and (iii) the expression of several receptors for sex hormones (highlighted in this review). 69 (iv) murine testis-derived multipotent germ cells 38 and (v) fat tissue-derived CD45-negative cells. 70 Moreover, by employing elutriation, a population of very small cells measuring~5 μm in diameter can be isolated-at FR25 (flow rate 25 ml/min) with ALDH high Lin -AA4.1 − markers-that do not radioprotect lethally irradiated mice and lack spleen colony-forming (CFU-S) activity, but if cotransplanted with short-term engrafting HSCs, produce delayed multilineage engraftment. 71 These latter cells have been recently confirmed to overlap with VSELs, and thus we became interested in the hematopoietic potential of CD45-negative VSELs. 15, 16 My group found that, similar to FR25 ALDH high lin − AA4.1 − stem cells, 71 VSELs freshly isolated from BM do not show any in vitro or in vivo hematopoietic activity in classical hematopoietic assays. Specifically, they do not grow colonies in methylcellulose and do not protect lethally irradiated animals, 15 which is one of the gold standard assays for HSCs. VSELs, however, do acquire hematopoietic potential after co-culture over OP9 stromal cells, in a similar manner as embryonic and induced pluripotent stem cells. 15, 16 CD45 − VSELs in OP9 co-cultures differentiate into CD45 + clonogenic hematopoietic progenitors but, more importantly, also into HSCs, which are able to establish long-term chimerism, both in primary as well as in secondary transplants. On the basis of these observations, we proposed that VSELs are the most primitive murine BM-residing population of stem cells that have the potential to become specified into the hematopoietic lineage and thus may share some of the characteristics of long-term repopulating HSCs (LT-HSCs). Hematopoietic differentiation of VSELs has been recently confirmed by other independent team. 18 Moreover, taking into consideration the possibility that VSELs can give rise to hemangioblasts that possess both hematopoietic and endothelial potential, recent work from an independent group employing well-controlled experiments demonstrated the ability of VSELs to give rise both in vitro and in vivo to endothelium. 19, 51, 52 In further support of this notion, we observed that VSELs highly express mRNA for the Flt-2 receptor (data not published).
HEMATOPOIETIC STEM CELLS AND THEIR RESPONSIVENESS TO SEX HORMONES
For a long time, the major problem with purified HSCs was that none of the proposed HSC populations 72 could be efficiently expanded ex vivo to increase in cell number. Rather, all previously available HSC expansion protocols lead to an increase in the number of more differentiated hematopoietic progenitor cells, 13, 72 and there were two possible explanations for this fact. First, that we still have not identified all factors operating in vivo in HSC niches that are required for self-renewal of these cells, and second, that even these cells that have been claimed to be most primitive have already entered a pathway of differentiation at the expense of their true self-renewing potential. Recently, however, significant progress has been made in this direction both in experimental [73] [74] [75] and clinical settings 76 by employing prostaglandin E2 73 or small molecular compounds such as, for example, aryl hydrocarbon receptor antagonist -SR-1. 76 Nevertheless, it is clear that in order to proceed with most optimal expansion, we should begin this process with the most primitive quiescent stem cell likely to be able to give rise to all these potential HSC candidates. I envision that such cells, which are at the top of the stem cell compartment hierarchy in adult BM, are VSELs because of all the reasons discussed above in this review (Figure 1a) .
Therefore, based on the assumption that HSCs are derived from VSELs and most likely are direct descendants of PGCs migrating during embryogenesis, 12, 17, 19, 30 my group tested the responsiveness of HSCs to several factors that stimulate VSELs and PGCs. One group of such factors was the gonadal and pituitary sex hormones. Of note an important source of SexH during development is placenta. In our studies, while gonadal sex hormones, including androgens 64, 65 and, as recently reported by us and others, estrogens, 64, 77 stimulate murine and human hematopoiesis, the role of pituitary sex hormones, including follicle-stimulating hormone (FSH) and luteinizing hormone (LH), have not yet been investigated in more details. To address this issue, we tested the expression of receptors for pituitary-derived sex hormones, such as FSH, LH and PRL, on purified murine BM cells enriched for HSCs and tested the functionality of these receptors in ex vivo signal transduction studies and in vitro clonogenic assays. 64, 65 Addition of sex hormones in clonogenic assays performed in the presence of suboptimal doses of hematopoietic cytokines and growth factors increased the clonogenecity of hematopoietic progenitor cells from all major lineages. 64, 65 In parallel, we performed receptor expression studies with murine and human VSELs. 64, 65 We also tested in a mouse model whether administration of pituitary-and gonad-derived sex hormones increases incorporation of bromodeoxyuridine (BrdU) into HSCs and expansion of hematopoietic clonogenic progenitors in mice and promotes recovery of blood counts in sublethally irradiated animals. 64 We reported that murine and human HSCs, and VSELs express functional FSH and LH receptors and that both proliferate in vivo as evaluated by the number of BrdU-accumulating HSCs and in vitro clonogenic assays in response to stimulation by suboptimal doses of hematopoietic cytokines after addition of pituitary sex hormones. 64, 65 Human and murine HSCs also responded to stimulation by PRL. 64, 65 We have performed similar experiments with gonadal sex hormones, including androgens, estrogens and progesterone. In support of these findings, we detected expression of mRNA in purified murine Sca-1 + HSCs as well as in human purified CD34 + cells and demonstrated that these receptors are also expressed at the protein level and are functional, as indicated by phosphorylation of intermediates in the MAPKp42/44-and AKT-dependent signaling pathways. 64, 65 In experiments in mice in vivo, we found that administration of sex hormones increases the number of proliferating HSCs in BM, 64 and this is accompanied by an increase in BM-residing VSEL proliferation in vivo, which further supports the involvement of VSELs in hematopoiesis. 64, 65 SEX HORMONES AND LEUKEMIA Sex hormones may also play a role in the pathogenesis of leukemia, as there are sex-dependent differences between males and females in the development of leukemia, lymphoma and myeloma, and males suffer more frequently from these disorders. 78 Nevertheless, the available literature on the potential role of SexHs in malignancies is mostly limited to the potential involvement of PRL, estrogen and androgen. [79] [80] [81] [82] [83] For example, it has been reported that human CD33 + blasts express the PRL receptor (PRLR), and PRL is an oncogene in rat Nb2 lymphoma cells 84 and an autocrine growth factor for the human T-cell leukemia Jurkat cell line. 85, 86 On the other hand, estrogen receptors (ESRs) and androgen receptors (ARs) were detected in sex hormone binding studies in cells isolated from AML and CML patients in addition to human hematopoietic cell lines. 87 Nevertheless, despite significant research effort, the effect of estrogens in leukemogenesis is somewhat controversial. For example, in support of ESR leukemia-promoting affects, the ESR gene promoter was found to be aberrantly hypermethylated in a majority of cases of pediatric ALL, adult ALL, adult AML and, in particular, blast crisis CML. [87] [88] [89] [90] By contrast, the disruption of ESRβ in mice causes myeloproliferative disease with lymphoid crisis, 91 which suggests that estrogen signaling can control proliferation of hematopoietic cells. In support of the latter possibility, an ESR agonist has been found to have an anti-proliferative effect on the growth of lymphoma cells, 92, 93 and 17alpha-estradiol was reported to be toxic against the human Jurkat T-cell line. 94 These observations may explain the protective effect of estrogens on hematopoietic malignancies in female patients, 95 which correlates with the fact that females seem to be more resistant to leukemia. 95 Nevertheless, while estrogens may have a protective role in developing leukemia and lymphoma, no evidence exists for a potential role of pituitary sex hormones, such as FSH and LH. This is important, as the FSH level increases with age as a result of gonadal dysfunction and lack of negative feedback from gonadal sex hormones, and it is known that age is one of the risk factors for developing hematopoietic malignancies. 96, 97 To address this issue, my team screened several human myeloid and lymphoid cell lines as well as leukemic AML and CML blasts isolated from patients for their expression of functional pituitary and gonadal sex hormone receptors. 78 We found that FSH, LH, PRL, androgen and progesterone (PRG) receptors were expressed by HEL, K562, THP-1, U937, KG-1a, HL-60 and DAMI cells. Human myeloid cell lines also expressed estrogen receptors alpha and beta (ESRα and β), with the exception of DAMI cells, which expressed ESRβ but not ESRα. Similarly, the lymphoid cell lines DAUDI, RAJI, NALM-6, JURKAT and MOLT4 expressed mRNA for FSH, LH, PRL, androgen and PRG receptors. At the same time, however, ESRα was not expressed by RAJI cells, and ESRβ mRNA expression was missing in the NALM-6 cell line. In parallel studies the FSH receptor was expressed by all 10 AML blast samples and 5 out of 8 CML blasts investigated by us. Moreover, while the mRNA for LH receptor was detectable by all AML and 4 out of 8 CML patient-derived cells, the TPRL receptor was expressed in 8 out of 10 blast samples from AML patients and in all 8 CML blast samples. Gonadal sex hormone receptor studies revealed that, while the AR was expressed in all AML and CML blast samples, 7 out of 10 AML and 7 out of 8 CML samples expressed ESRα, and 8 out of 10 AML and all CML blast samples expressed ESRβ. Finally, PGR was expressed in half of the AML and 3 of 8 CML blast samples. 78 In functional studies, we observed that FSH and LH stimulate migration, adhesion and proliferation of several human leukemia cell lines as well as AML and CML blasts isolated from patients. 78 This effect seemed to be direct, as the receptors for these hormones responded to stimulation by phosphorylation of intracellular pathways involved in cell proliferation. We found that all of the myeloid cell lines as well as B and T lymphoid cell lines employed in our studies responded to sex hormones by chemotaxis in Transwell assays and by adhesion to fibronectincoated plates. Moreover, our proliferation studies, performed in 0.5% BSA with or without supplementation with SexHs, revealed that most of the leukemic cell lines employed in our study responded to stimulation by SexHs and that the highest responsiveness was observed to stimulation by the pituitary sex hormones (FSH, LH, and PRL), and a somewhat weaker response was observed after stimulation with PRG and estradiol. 78 Finally, in in vivo experiments, when exposed to FSH or LH stimulation before intravenous injection into immunodeficient mice, human THP-1 leukemic cells showed increased seeding efficiency into murine BM, spleen, lung, and liver. 78 
CONCLUSIONS
Normal and malignant human HSCs as well as established hematopoietic cell lines express functional receptors not only for gonadal but also for pituitary and placental sex hormones. Expression of these receptors on HSCs suggests a potential developmental link between PGCs, VSELs and hematopoiesis (Figure 1b) . In this context, it is proposed that VSELs are precursors of LT-HSCs, contributing to steady-state hematopoiesis and/or stress-induced hematopoiesis. In support of the latter possibility, BMP-4, a well-known PGC growth factor, has been reported to be involved in several models of stress hematopoiesis. [98] [99] [100] We also found that intravenous injection of BMP-4 into mice increases BrdU accumulation in VSELs and HSCs (manuscript in preparation). As always, any challenging results or concepts as these discussed in the current review will need further studies and confirmation by additional independent groups.
